Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.
Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.
复制标题
DOI:
10.1016/j.cell.2013.10.042
复制
发表时间:
2013-11-21
期刊:
影响因子:
64.5
通讯作者:
Chen C
中科院分区:
文献类型:
--
作者:
Chen R;Zhang J;Fan N;Teng ZQ;Wu Y;Yang H;Tang YP;Sun H;Song Y;Chen C
Marijuana has been used for thousands of years as a treatment for medical conditions. However, untoward side effects limit its medical value. Here we show that synaptic and cognitive impairments following repeated exposure to Δ9-tetrahydrocannabinol (Δ9-THC) are associated with the induction of cyclooxygenase-2 (COX-2), an inducible enzyme that converts arachidonic acid to prostanoids, in the brain. COX-2 induction by Δ9-THC is mediated via CB1 receptor-coupled G-protein βγ subunits. Pharmacological or genetic inhibition of COX-2 blocks down-regulation and internalization of glutamate receptor subunits and alterations of the dendritic spine density of hippocampal neurons induced by repeated Δ9-THC exposures. Ablation of COX-2 also eliminates Δ9-THC-impaired hippocampal long-term synaptic plasticity, spatial, and fear memories. Importantly, the beneficial effects of decreasing β-amyloid plaques and neurodegeneration by Δ9-THC in Alzheimer’s disease animals are retained in the presence of COX-2 inhibition. These results suggest that the applicability of medical marijuana would be broadened by concurrent inhibition of COX-2.
登录
查看更多内容
DOI:
10.1007/978-3-540-88955-7_6
发表时间:
2009-01-01
期刊:
BEHAVIORAL NEUROBIOLOGY OF THE ENDOCANNABINOID SYSTEM
影响因子:
--
作者:
Alger, Bradley E.
通讯作者:
Alger, Bradley E.
影响因子:
16.2
作者:
Delaney, Andrew J.;Crane, James W.;Sah, Pankaj
通讯作者:
Sah, Pankaj
影响因子:
--
作者:
Dave, Kathleen A.;Platel, Jean-Claude;Bordey, Angelique
通讯作者:
Bordey, Angelique
影响因子:
2
作者:
Hoffman, Alexander F.;Oz, Murat;Lupica, Carl R.
通讯作者:
Lupica, Carl R.
影响因子:
4.8
作者:
Brock, TG;McNish, RW;Peters-Golden, M
通讯作者:
Peters-Golden, M